Investment performance of life-science venture capital investment funds, persistence, and subsector analysis

Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management, 2007.

Bibliographic Details
Main Author: Behrens, Jeffrey S
Other Authors: Antoinette Schoar and Stanley N. Lapidus.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2007
Subjects:
Online Access:http://hdl.handle.net/1721.1/38334
_version_ 1826189471977046016
author Behrens, Jeffrey S
author2 Antoinette Schoar and Stanley N. Lapidus.
author_facet Antoinette Schoar and Stanley N. Lapidus.
Behrens, Jeffrey S
author_sort Behrens, Jeffrey S
collection MIT
description Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management, 2007.
first_indexed 2024-09-23T08:15:38Z
format Thesis
id mit-1721.1/38334
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T08:15:38Z
publishDate 2007
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/383342019-04-14T07:27:49Z Investment performance of life-science venture capital investment funds, persistence, and subsector analysis Behrens, Jeffrey S Antoinette Schoar and Stanley N. Lapidus. Sloan School of Management. Harvard University--MIT Division of Health Sciences and Technology. Sloan School of Management. Harvard University--MIT Division of Health Sciences and Technology. Sloan School of Management. Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management, 2007. Vita. Includes bibliographical references (leaf 28). Venture capital investment performance data and performance attribution are not typically published. Venture investors articulate (and sell to LPs) conflicting strategies; the popular business literature and culture is rife with rapidly changing beliefs about the relative attractiveness of healthcare venture subsectors, particularly therapeutics and devices. To examine these issues in a more rigorous format I developed a dataset of healthcare venture deals, scored each deal with a new metric ("jb-score"), and assigned each portfolio company to appropriate subsectors. This dataset was then used to examine subsector performance, persistence, and fund strategy attribution (pure vs. mixed healthcare strategies.) Specifically, I found that the performance characteristics of device and therapeutic (aka biotech or drug) investments are similar: both subsectors evidence similar jb-scores and firms who invest heavily in these subsectors show similar levels of persistent overperformance with devices showing somewhat higher persistence. Firms that focus on one subsector do not perform as well as firms that follow a more balanced strategy. Finally, I examine the validity of the jb-score and offer some suggestions for future improvements. by Jeffrey S. Behrens. M.B.A. S.M. 2007-08-03T18:31:02Z 2007-08-03T18:31:02Z 2007 2007 Thesis http://hdl.handle.net/1721.1/38334 156912606 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 32 leaves application/pdf Massachusetts Institute of Technology
spellingShingle Harvard University--MIT Division of Health Sciences and Technology.
Sloan School of Management.
Behrens, Jeffrey S
Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title_full Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title_fullStr Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title_full_unstemmed Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title_short Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
title_sort investment performance of life science venture capital investment funds persistence and subsector analysis
topic Harvard University--MIT Division of Health Sciences and Technology.
Sloan School of Management.
url http://hdl.handle.net/1721.1/38334
work_keys_str_mv AT behrensjeffreys investmentperformanceoflifescienceventurecapitalinvestmentfundspersistenceandsubsectoranalysis